The molecular role of mast cells in atherosclerotic cardiovascular disease

Molecular Medicine Today

Volumn 6, Issue 8, 2000, Pages 304-308

  Kelley, Jim L ^a   Chi, David S ^a   Abou Auda, Wael ^a   Smith, J Kelly ^a   Krishnaswamy, Guha ^a  

^a East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION; CELL SECRETION; CORONARY ARTERY ATHEROSCLEROSIS; CYTOKINE RELEASE; HUMAN; MAST CELL; PATHOGENESIS; REVIEW;

EID: 0034254447     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(00)01747-0     Document Type: Note

References (36)

1. Kovanen P.T. Role of mast cells in atherosclerosis. Chem. Immunol. 62:1995;132-170.
2. Metcalf D.D.et al. Mast cells. Physiol. Rev. 77:1997;1033-1079.
3. Schwartz C.J.et al. Atherosclerosis as an inflammatory process. the roles of the monocyte-macrophage Ann. New York Acad. Sci. 454:1985;115-120.
4. Ross R. Atherosclerosis, an inflammatory disease. New Engl. J. Med. 340:1999;115-126.
5. LaRosa J.C. Atherogenesis and its relationship to coronary risk factors. clinical COORNERSTONE. 1:1998;3-11.
6. Church M.K., Levi-Schaffer F. The human mast cell. J. Allergy Clin. Immunol. 99:1997;155-160.
7. Schwartz L.B. The mast cell. Kelley W.N.et al. Textbook of Rheumatology. 1997;161-175 W.B. Saunders Company, Philadelphia.
8. Krishnaswamy G.et al. Multifunctional cytokine expression by human mast cells. regulation by T cell membrane contact and glucocorticoids J. Interferon Cytokine Res. 17:1997;167-176.
9. Bradding P. Review. Human mast cell cytokines Clin. Exp. Allergy. 26:1996;13-19.
10. Waltner-Romen M.et al. A previously unrecognized site of local accumulation of mononuclear cells. the vascular-associated lymphoid tissue J. Histochem. Cytochem. 46:1998;1347-1350.
11. Kaartinen M.et al. Mast cell infiltration in acute coronary syndromes. implications for plaque rupture J. Am. Coll. Cardiol. 32:1998;606-612.
12. Kovanen P.T. Mast cells in human fatty streaks and atheromas. implications for intimal lipid accumulation Curr. Opin. Lipidology. 7:1996;281-286.
13. Jeziorska M.et al. Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries. J. Pathol. 182:1997;115-122.
14. Kullo I.J.et al. Vulnerable plaque. pathobiology and clinical implications Ann. Intern. Med. 129:1998;1050-1060.
15. Krishnaswamy G.et al. Vulnerable plaque. pathobiology and clinical consequences Ann. Intern. Med. 131:1999;392-393.
16. Kovanen P.T.et al. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation. 92:1995;1084-1088.
17. Sillaber C.et al. The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis. J. Immunol. 162:1999;1032-1041.
18. Steinberg D.et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. New Engl. J. Med. 320:1989;915-924.
19. Lee M.et al. Mast cell-mediated inhibition of reverse cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 12:1992;1329-1335.
20. Gruber B.L.et al. Human mast cells activate fibroblasts. Tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J. Immunol. 158:1997;2310-2317.
21. He S.H.et al. Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase. Selective enhancement of eosinophil recruitment by histamine J. Immunol. 159:1997;6216-6225.
22. Compton S.J.et al. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression. tryptase induces expression of mRNA for IL-1 beta and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells J. Immunol. 161:1998;1939-1946.
23. Johnson J.L.et al. Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 18:1998;1707-1715.
24. Saarinen J.et al. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J. Biol. Chem. 269:1994;18134-18140.
25. Kovanen P.T. Chymase-containing mast cells in human arterial intima. implications for atherosclerotic disease Heart Vessels Suppl. 12:1997;125-127.
26. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol. Chem. Hoppe-Seyler. 378:1997;151-160.
27. Dollery C.M.et al. rMatrix metalloproteinases and cardiovascular disease. Circ. Res. 77:1995;863-868.
28. Gruber B.L.et al. Synovial procollagenase activation by human mast tryptase dependence upon matrix metalloproteinase 3 activation. J. Clin. Invest. 84:1989;1657-1662.
29. Lees M.et al. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Eur. J. Biochem. 223:1994;171-177.
30. Mirza H.et al. Mitogenic responses mediated through the protease-activated receptor-2 are induced by expressed forms of mast cell alpha- or beta-tryptases. Blood. 90:1997;3914-3922.
31. Kitamura Y.et al. Higher susceptibility of mast-cell-deficient W/WV mutant mice to brain thromboembolism and mortality caused by intravenous injection of India ink. Am. J. Pathol. 122:1986;469-480.
32. Hatanaka K.et al. High susceptibility to ADP-induced thrombus formation in mast cell-deficient W/Wv mice. Thromb. Res. 40:1985;453-464.
33. Kauhanen P.et al. Effects of skin mast cells on bleeding time and coagulation activation at the site of platelet plug formation. Thromb. Haemost. 79:1998;843-847.
34. Thomas V.A.et al. Human mast cell tryptase fibrinogenolysis. kinetics, anticoagulation mechanism and cell adhesion disruption Biochem. J. 37:1998;2291-2298.
35. Maier M.et al. Inactivation of human high molecular weight kininogen by human mast cell tryptase. J. Immunol. 130:1983;2352-2356.
36. Lassila R.et al. Native macromolecular heparin proteoglycans exocytosed from stimulated rat serosal mast cells strongly inhibit platelet-collagen interactions. Arterioscler. Thromb. Vasc. Biol. 17:1997;3578-3587.